PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Symptom | C0239946|liver fibrosis |
| Sentences | 87 |
| PubMedID- 19874490 | Conclusions: ultrasonic arfi elastography is a novel, non-invasive and reliable method for the assessment of liver fibrosis in patients with chronic liver disease. |
| PubMedID- 23925270 | Purpose: to assess the feasiblity of magnetic resonance (mr) susceptibility-weighted (sw) imaging as a tool to evaluate liver fibrosis grades in patients with chronic liver diseases (cld) utilizing signal intensity (si) measurements, with histopathologic findings as the reference standard. |
| PubMedID- 24976523 | Accurate evaluation of the degree of liver fibrosis in patients with chronic liver diseases (cld) is crucial, as liver fibrosis is important in determining the prognosis of liver diseases. |
| PubMedID- 25608776 | The aim of our pilot study was to assess the clinical performance of the apparent diffusion coefficient (adc) of liver parenchyma for the assessment of liver fibrosis in patients with non-alcoholic fatty liver disease (nafld). |
| PubMedID- 20955966 | liver fibrosis is the sequel of chronic liver diseases and the main reason for increased mortality in affected patients. |
| PubMedID- 20540856 | Conclusions: both timp-1 and -2 may reflect the state of liver fibrosis in children with nonalcoholic fatty liver disease, and serum timp-1 appears to be more reliable. |
| PubMedID- 21497738 | Multiple etiologies of liver disease lead to liver fibrosis through integrated signaling networks that regulate the deposition of extracellular matrix. |
| PubMedID- 23907428 | This imaging modality is currently used to determine the degree of liver fibrosis in patients with end-stage liver disease. |
| PubMedID- 22087168 | liver fibrosis in patients with chronic liver diseases: are laboratory tests useful to diagnosis? |
| PubMedID- 20531020 | The aspartate aminotransferase-to-platelet ratio index (apri) is a safe and simple method to assess liver fibrosis in patients with chronic liver diseases. |
| PubMedID- 24627597 | Although liver biopsy remains the reference standard for evaluating the extent of liver fibrosis in patients with chronic liver diseases, several non-invasive methods have been developed as alternatives to liver biopsies. |
| PubMedID- 22872786 | Tgf-β has been shown to correlate well with the presence of liver fibrosis in patients with alcoholic liver disease (ald) and hcv.92 however, its release is injury-dependent and correlates with alt and ast.93,94 therefore it was suggested as a more appropriate marker of necrosis rather than fibrogenesis. |
| PubMedID- 25326152 | Background: accurately evaluating liver fibrosis in patients with non-alcoholic fatty liver disease (nafld) is important for identifying those who may develop complications. |
| PubMedID- 25393946 | Purpose: to evaluate the accuracy of shear-wave elastography (swe) for staging liver fibrosis in patients with diffuse liver disease (including patients with hepatitis c virus hcv) and to determine the relative accuracy of swe measurements obtained from different hepatic acquisition sites for staging liver fibrosis. |
| PubMedID- 26357427 | Its diagnostic usefulness for the liver fibrosisof patients with chronic liver disease has been reported by several studies since it wasintroduced by sandrin et al10). |
| PubMedID- 20731129 | The purpose of the study: determination of the diagnostic value of ultrasound elastometry of liver (uel) in the assessment of liver fibrosis in patients with chronic diffuse liver diseases (cdld). |
| PubMedID- 22110596 | Moreover, adiponectin has been shown to be associated with progression of liver fibrosis in patients with chronic liver disease , , . |
| PubMedID- 22530059 | The serum opn level could thus be considered as an independent factor in estimating significant liver fibrosis in patients with alcoholic liver disease. |
| PubMedID- 26550019 | Those approaches mimic the process of autoimmune liver diseases provoking liver fibrosis. |
| PubMedID- 24267737 | Background & aims: liver stiffness (ls) measurement using transient elastography allows for accurate evaluation of liver fibrosis in patients with chronic liver disease. |
| PubMedID- 21050091 | Transient elastography (fibroscan((r))) is a noninvasive method proposed for the assessment of liver fibrosis in patients with chronic liver diseases by measuring liver stiffness. |
| PubMedID- 23227248 | Serum gamma-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseases. |
| PubMedID- 24845365 | Background: hepatitis c virus (hcv) is the causative agent of chronic liver diseases, which usually lead to liver fibrosis, liver cirrhosis, and hepatocellular carcinoma (hcc). |
| PubMedID- 22893866 | Transient elastography (te, fibroscan(r)) is a novel non-invasive method for assessment of liver fibrosis with chronic liver disease. |
| PubMedID- 24114824 | Arfi cut-off values and significance of standard deviation for liver fibrosis staging in patients with chronic liver disease. |
| PubMedID- 25501710 | liver fibrosis, a major cause of end-stage liver diseases, is closely regulated by multiple growth factors and cytokines. |
| PubMedID- 25342166 | Background: acoustic radiation force impulse (arfi) elastography is a reliable diagnostic device for quantitative non-invasive assessment of liver fibrosis in patients with chronic liver disease. |
| PubMedID- 25540037 | The development of chronic hepatitis b virus-mediated liver disease may lead to liver fibrosis, cirrhosis and eventually hepatocellular carcinoma. |
| PubMedID- 24966597 | The pathogenesis of liver fibrosis associated with alcoholic liver disease, non-alcoholic fatty liver disease and viral hepatitis are also discussed to emphasize the various mechanisms involved in liver fibrosis. |
| PubMedID- 22239518 | There is increasing interest in developing noninvasive means to evaluate liver fibrosis in patients with chronic liver disease to determine disease severity, prognosis and optimal treatment. |
| PubMedID- 23878281 | Purpose: to evaluate the diagnostic performance of gadoxetic acid-enhanced magnetic resonance (mr) imaging in the staging of liver fibrosis in patients with diffuse chronic liver diseases (clds) and to investigate the factors that may influence the results. |
| PubMedID- 26486293 | Backgroundliver biopsy is recommended as the gold standard method for assessing the stage of liver fibrosis in patients with chronic liver disease. |
| PubMedID- 25100997 | Although the composition of fibrogenic myofibroblasts varies dependent on etiology of liver injury, liver resident hepatic stellate cells and portal fibroblasts are the major source of myofibroblasts in fibrotic liver in both experimental models of liver fibrosis and in patients with liver disease. |
| PubMedID- 22333291 | Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation. |
| PubMedID- 25305349 | We conducted a meta-analysis of individual participant data collected from published studies to assess the diagnostic accuracy of mre for staging liver fibrosis in patients with chronic liver diseases (cld). |
| PubMedID- 23258240 | Predictors of liver fibrosis in patients with non-alcoholic fatty liver disease. |
| PubMedID- 23626613 | furthermore, the risk of thrombosis in patients with non-alcoholic fatty liver disease was associated with advanced liver fibrosis and nonalcoholic steatohepatitis. |
| PubMedID- 24808418 | More recent developments have led to methods for quantifying important liver metabolites, including lipids and iron, and liver fibrosis, the hallmark of chronic liver disease. |
| PubMedID- 24811766 | Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease using acoustic radiation force impulse elastography. |
| PubMedID- 24798049 | The combination of liver stiffness measurement and nafld fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease. |
| PubMedID- 21552420 | Alcoholic hepatitis, nonalcoholic steatohepatitis, and viral hepatitis are the 3 major causes of chronic liver diseases, leading to liver fibrosis, cirrhosis, and the end-stage of hepatocellular carcinoma. |
| PubMedID- 26143457 | Different non-invasive methods are available for detecting liver fibrosis in patients with chronic liver disease. |
| PubMedID- 25884329 | In addition, lps, a stimulus known to induce mp release from monocytes and macrophages, has been shown to be associated with liver fibrosis in patients with hcv-related liver disease, though the mechanism by which lps contributes to liver fibrosis is not well understood . |
| PubMedID- 24827629 | Background/aims: we sought to examine whether the presence of gallstone disease (gd) in patients with biopsy-proven nonalcoholic fatty liver disease (nafld) is associated with liver fibrosis and histological nonalcoholic steatohepatitis (nash) score. |
| PubMedID- 22100369 | Purpose: to evaluate the diagnostic value of diffusion-weighted magnetic resonance imaging (dwmri) and transient elastography (te) in quantification of liver fibrosis in patients with chronic cholestatic liver diseases. |
| PubMedID- 23837140 | The aim of this study was to compare the accuracy of te, arfi and rte, for the assessment of liver fibrosis in patients with chronic liver diseases. |
| PubMedID- 23049764 | To overcome the limitations of lb in assessing the severity of liver fibrosis in patients with chronic liver disease, a great effort has been made to develop and validate noninvasive methods for detecting liver fibrosis. |
| PubMedID- 23811938 | Background: ls values using transient elastography provides accurate assessment of liver fibrosis in patients with chronic liver disease. |
| PubMedID- 22872942 | liver fibrosis is associated with chronic liver diseases, and may evolve into cirrhosis that may be complicated by liver failure and portal hypertension. |
| PubMedID- 23480804 | liver fibrosis in patients with non-alcoholic fatty liver disease: diagnostic options in clinical practice. |
Page: 1 2